JPM 2022

Sage wants to 'raise the bar' on depression meds

Existing meds haven't delivered on treating the depression that impacts millions of Americans, and Sage wants to fix that with quick start zuranolone.

Kyle LaHucik Jan 19, 2022 4:30pm

Johnson & Johnson's JLABS: Taming the beast

Jan 19, 2022 3:30pm

Bayer's new R&D chief wants to push past Aspirin legacy

Jan 18, 2022 12:10pm

Pharma reflects on the 'aha! moments' of the pandemic

Jan 18, 2022 11:30am

Bausch + Lomb files IPO for its eye care spinout

Jan 14, 2022 10:45am

JPM 2022: Licensing and research tie-ups trump M&A

Jan 14, 2022 9:30am